Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ablative therapies for the columnar-lined esophagus

R E Sampliner1

  • 1Department of Medicine, University of Arizona Health Sciences Center, Tucson, USA.

Gastroenterology Clinics of North America
|October 6, 1997
PubMed
Summary

Endoscopic ablative therapy shows promise in reversing Barrett's esophagus and reducing adenocarcinoma risk. Combination therapy, including acid control and ablation, may be effective when other treatments fail.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Barrett esophagus.

Current opinion in gastroenterology·2006
Same author

Barrett esophagus.

Current opinion in gastroenterology·2006
Same author

Correlation of gastroesophageal reflux disease symptoms characteristics with long-segment Barrett's esophagus.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2006
Same author

A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results.

Gut·2006
Same author

Association of ablation of Barrett's esophagus with high grade dysplasia and adenocarcinoma of the gastric cardia.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2006
Same author

The methylene blue blues.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2006

Area of Science:

  • Gastroenterology
  • Endoscopic Therapeutics

Background:

  • Barrett's esophagus carries a risk of adenocarcinoma development.
  • Previous medical or surgical therapies may not fully reverse the condition.

Purpose of the Study:

  • To review endoscopic ablative therapies for Barrett's esophagus.
  • To evaluate combination therapy including acid control and ablation.

Main Methods:

  • Review of preliminary results from endoscopic ablation techniques (laser, photodynamic therapy, electrocoagulation).
  • Combination therapy involving pharmacologic or surgical acid control and endoscopic mucosal ablation.

Main Results:

  • Endoscopic ablative therapy can potentially reduce adenocarcinoma risk.
  • Combination therapy may reverse Barrett's esophagus when prior treatments were unsuccessful.
  • Higher doses of proton pump inhibitors are often required for acid control.

Conclusions:

  • Endoscopic ablative therapies aim to eliminate intestinal metaplasia and associated cancer risk.
  • Further large-scale, long-term trials are needed to validate these techniques.
  • Improved risk stratification criteria are necessary for selecting patients for combination therapy.

Related Experiment Videos